It seems as though no matter where you go these days, you’re bound to encounter a product containing cannabidiol, commonly referred to as CBD. As you have likely heard by now, the 2018 Farm Bill (formally, the Agriculture Improvement Act of 2018), which was signed into law on December 20, 2018, legalized the regulated production of hemp. This triggered a corresponding amendment of the Controlled Substances Act (CSA), removing “hemp” from the definition of marijuana and specifically excluding “tetrahydrocannabinols (THC) in hemp” from the listing of Schedule 1, or most dangerous, drugs. Hemp is now defined as cannabis plants and derivatives thereof, such as CBD, that contain “no more than 0.3% THC on a dry-weight basis,” and is no longer a controlled substance under the CSA. However, hemp remains subject to regulation by both state and federal government agencies and violation of production and distribution of hemp in violation of state law can result in criminal penalties and seizure of the product.

Registering Trademarks

What does all this mean for brand owners? For one, the U.S. Patent and Trademark Office (USPTO) has received a flood of applications to register trademarks for use with CBD-infused products. If you’re looking to break into this fast-growing market, you’ll want to select a trademark or brand name for your product and ensure that it is protected. You’ll also want to make sure no one else is already using the same or similar trademark for identical or related goods (or potentially services), as that could raise potential obstacles (such as infringement claims) that could stymie moving forward with your brand. Conducting a comprehensive trademark search is always a good place to start when establishing a new brand. Comprehensive searches cover records from both U.S. state and federal trademark databases as well as common law databases, such as company and domain name registries and use of similar trademarks on Internet websites.

Once the search is done and the coast appears clear, you’ll want to secure registration for your trademark. While certain hemp derived CBD-based products content are no longer criminal under federal law, and the trademarks under which they are used are capable of federal registration, there are several important guidelines of which to be aware when seeking U.S. trademark registration for these types of marks and products.

First, as noted above, only hemp-derived CBD that contains no more than 0.3% THC is federally legal. Cannabis and CBD-derived from marijuana, i.e., Cannabis sativa L. with more than 0.3% THC on a dry-weight basis, is still a narcotic controlled substance under federal law, and applications encompassing such goods will be refused federal registration. Additionally, the goods listed in the trademark application must specify that they contain less than 0.3% THC. If not, the Trademark Examiner will issue an office action to inquire whether the goods comply with federal law. Furthermore, if the terms “HEMP,” “CBD,” or another variation of the terms cannabis or cannabidiol (e.g., “CANNA”) are included as part of the applied-for mark, this will also trigger an inquiry by the Trademark Examiner as to whether and to what extent CBD is featured as an ingredient of the products (or characteristic of the services), and whether the provision of the goods and/or services in U.S. commerce would be deemed lawful.

As also stated above, to be considered legal, hemp must be cultivated in compliance with relevant state and federal regulations. Accordingly, it is likely that the Trademark Examiner will inquire into whether the hemp from which the CBD was derived was grown within the U.S., was obtained from an authorized grower or supplier of industrial hemp, and whether the covered goods and/or services to be provided under the applied-for mark comply with federal law. Accordingly, make sure you have all relevant information and are prepared to answer these questions. The USPTO issued an Examination Guide to help trademark applicants better understand its procedures for processing applications for goods and services containing or concerning CBD (see here).

Certain states will also register cannabis related trademarks. Each state has its own requirements for trademark registration, and state trademark registrations only confer the benefits of registration within the boundaries of that state. Accordingly, if you seek to register a trademark in a state, it is important to check state law and, specifically, the treatment of hemp and marijuana in that state.

Regulatory Considerations

The Farm Bill explicitly preserved the authority of the Food and Drug Administration (FDA) to regulate products falling within the parameters of the Federal Food, Drug and Cosmetic Act (FDCA). Thus, while hemp-derived CBD at less than 0.3% has been removed from the Controlled Substances list, it is important to note that food, beverages, dietary supplements, pet treats, and other consumables containing added CBD, or THC of any amount, could still be considered unlawful as containing an unapproved food additive or containing an additive that is not generally recognized as safe. Additionally, FDA has noted that the FDCA precludes the inclusion in a food or dietary supplement of any active ingredient approved as a drug. A drug containing CBD, Epidiolex, was recently approved for the treatment of certain seizures. Thus, the FDA’s position is that the inclusion of CBD in a food or dietary supplement violates the FDCA. However, this prohibition on CBD-infused consumable products has not stopped scores of companies from producing, marketing and selling CBD-infused waters, teas, candies, and a multitude of other items for both human and animal consumption. Companies selling such items could receive a warning letter from the FDA, and the FDA, along with state and/or federal agencies, could decide to take enforcement action.

That said, the FDA has stated that the agency lacks information about the safety of consumables and has opened a docket to receive information. 84 Fed Reg 12969 (April 3, 2019). In the interim, the FDA has taken vigorous action against companies that market products containing CBD if any sort of claim to health or therapeutic benefit is made. This includes claims or marketing about well-being in addition to claims about treating or managing disease. While the USPTO will generally not inquire into a brand’s marketing claims when determining whether to grant registration of a mark, it is extremely important to be aware of the restrictions on marketing contained in the FDCA as you prepare to bring your products to market. To assist the public with understanding the current FDA regulation of the CBD products, the FDA published a list of frequently asked questions and answers (see here).


Lisa Rosaya is a partner in our New York office. Lisa represents clients in the consumer products, cosmetics, fashion, food and beverage, social media, telecommunications and media/entertainment industries in connection with legal issues arising in the IP, Internet and advertising areas. Her particular areas of expertise are trademark selection clearance, prosecution, opposition and cancellation proceedings; copyright and trademark licensing, enforcement and infringement matters; domain name disputes and labeling and advertising issues.


Jur Strobos is a partner in our DC office. Jur is a former FDA policy official and investigator. He advises clients on matters under the jurisdiction of the US Food and Drug Administration (food, cosmetics, tobacco, methadone clinics, and medical products) and the Drug Enforcement Administration. He is licensed in California and also advises on compliance with California health care laws.


Lindsey Utrata is an associate in our New York office. Lindsey advises clients on trademark portfolio and brand management matters, as well as brand enforcement issues. Her clients include companies from the consumer and personal care, food and beverage, telecommunications, media and entertainment, fashion and luxury goods, social media, and computer software industries.